CD274 and neoplasm: Other important targets in cancer therapy, especially in immunooncology, are the programmed cell death-ligand 1 (PD-L1) and the programmed cell death protein (PD-1), which promote tumor cell-specific T cell inactivation or apoptosis and hence lead to tumor cell growth and enhance tumor immune escape [21].